Barclays PLC Edwards Lifesciences Corp Call Options Transaction History

Barclays PLC

14 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 15, 2024	SELL	$59.7 - $93.78 $7.76 Million - $12.2 Million	-130,000 Reduced 65.0%	70,000 $4.62 Million
Q2 2024 Aug 14, 2024	BUY	$84.3 - $94.31 $16.9 Million - $18.9 Million	200,000 New	200,000 $18.5 Million
Q1 2023 May 04, 2023	BUY	$74.26 - $84.51 $2.01 Million - $2.28 Million	27,000 New	27,000 $2.23 Million
Q1 2020 May 13, 2020	SELL	$52.41 - $81.0 $655,125 - $1.01 Million	-12,500 Reduced 32.47%	26,000 $4.9 Million
Q4 2019 Feb 10, 2020	BUY	$71.7 - $82.09 $1.07 Million - $1.22 Million	14,900 Added 63.14%	38,500 $8.98 Million
Q3 2019 Nov 14, 2019	BUY	$61.55 - $75.43 $344,680 - $422,408	5,600 Added 31.11%	23,600 $5.19 Million
Q2 2019 Aug 14, 2019	SELL	$55.74 - $64.41 $2.87 Million - $3.32 Million	-51,500 Reduced 74.1%	18,000 $3.33 Million
Q1 2019 May 15, 2019	BUY	$47.89 - $64.05 $986,534 - $1.32 Million	20,600 Added 42.13%	69,500 $13.3 Million
Q4 2018 Feb 14, 2019	SELL	$46.41 - $56.94 $1.42 Million - $1.74 Million	-30,500 Reduced 38.41%	48,900 $7.49 Million
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $2.6 Million - $3.3 Million	56,900 Added 252.89%	79,400 $13.8 Million
Q2 2018 Aug 14, 2018	BUY	$42.45 - $51.3 $577,320 - $697,680	13,600 Added 152.81%	22,500 $3.28 Million
Q1 2018 May 15, 2018	SELL	$37.19 - $47.45 $357,024 - $455,520	-9,600 Reduced 51.89%	8,900 $1.24 Million
Q4 2017 Feb 14, 2018	BUY	$33.79 - $39.39 $10,137 - $11,817	300 Added 1.65%	18,500 $2.09 Million
Q3 2017 Nov 14, 2017	BUY	$36.29 - $38.83 $660,478 - $706,706	18,200	18,200 $1.99 Million

1,350

457M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $46.3B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.